Free tool
Healthcare stocks
We cover 34 companies in the Healthcare sector. The median market value in the group is $264.01B. Across the group, the median move over the past trading day is −0.15%. 85% of the 34 with a 200-day average trade above it. Price change over the past year runs from −11.2% to +74.7% across the middle 80 percent of the group, with a median of +28.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
34 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,063.40 EUR | −0.47% | +17.71% | +68.40% |
| LLY | Eli Lilly and Company | $1,233.66 | +3.02% | +14.58% | +78.28% |
| LILY34.SA | Eli Lilly and Company | 211.20 BRL | +3.30% | +9.59% | +69.06% |
| JNJ.DE | Johnson & Johnson | 231.70 EUR | −2.53% | +32.60% | +54.31% |
| JNJ | Johnson & Johnson | $273.14 | +2.70% | +33.19% | +56.92% |
| JNJB34.SA | Johnson & Johnson | 93.72 BRL | +2.97% | +26.23% | +48.73% |
| 4AB.DE | AbbVie Inc. | 226.10 EUR | −2.54% | +17.94% | +29.69% |
| ABBV | AbbVie Inc. | $265.79 | +3.46% | +17.81% | +31.10% |
| ABBV34.SA | AbbVie Inc. | 85.03 BRL | +3.35% | +9.69% | +23.44% |
| MRCK34.SA | Merck & Co., Inc. | 100.37 BRL | +19.93% | +38.35% | +77.08% |
| 6MK.DE | Merck & Co., Inc. | 129.28 EUR | +11.62% | +44.70% | +83.96% |
| RHO.DE | Roche Holding AG | 400.20 EUR | −0.15% | +12.54% | +39.70% |
| MRK | Merck & Co., Inc. | $156.45 | +19.65% | +48.06% | +88.17% |
| NOT.DE | NOVARTIS AG N | 135.46 EUR | −3.15% | +18.61% | +27.82% |
| N1VS34.SA | Novartis AG | 82.08 BRL | +2.40% | +11.52% | +20.51% |
| NVS | Novartis AG | $159.98 | +2.48% | +18.99% | +31.84% |
| AZN.L | AstraZeneca PLC | 12,110.00 GBP | −6.41% | −10.89% | +1.98% |
| AZN.ST | AstraZeneca PLC | 1,568.00 SEK | −6.12% | −7.36% | +2.47% |
| AZN | AstraZeneca PLC | $169.66 | +0.01% | −6.39% | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | 144.34 BRL | +0.85% | −12.75% | +1.51% |
| AMG.DE | Amgen Inc. | 378.10 EUR | +9.72% | +37.91% | +56.55% |
| AMGN34.SA | Amgen Inc. | 81.36 BRL | +17.28% | +69.77% | +47.86% |
| AMGN | Amgen Inc. | $442.24 | +17.54% | +36.94% | +56.64% |
| TMO | Thermo Fisher Scientific Inc. | $628.74 | +12.37% | +6.22% | +28.46% |
| TN8.DE | Thermo Fisher Scientific Inc. | 529.40 EUR | +4.71% | +5.35% | +27.50% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.27 BRL | +13.34% | −0.04% | +22.09% |
| NVO | Novo Nordisk A/S | $48.66 | −2.03% | −3.71% | −10.46% |
| NOV.DE | Novo Nordisk A/S | 40.03 EUR | −10.35% | +20.19% | +11.69% |
| NOVO-B.CO | Novo Nordisk A/S | 299.25 DKK | −10.78% | −6.26% | −13.21% |
| N1VO34.SA | Novo Nordisk A/S | 30.64 BRL | −2.73% | −12.21% | −17.65% |
| NVO.WA | NVONORDSK | 171.66 PLN | −9.40% | −3.40% | −11.47% |
| ABT | Abbott Laboratories | $116.13 | +11.14% | −5.43% | −10.54% |
| ABTT34.SA | Abbott Laboratories | 49.85 BRL | +12.07% | −10.73% | −15.33% |
| ABL.DE | Abbott Laboratories | 99.80 EUR | +5.14% | −4.18% | −9.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.